Original ResearchPublished 8 October 2026A zebrafish model of NEXMIF-related encephalopathy identified drivers of hyperlocomotion and provides a scalable platform for drug discoveryBeatriz Bernal-Bermúdez · Francisco J. Martínez-Morcillo · Inmaculada Fuentes-Martínez · Alicia Martínez-López · María L. Cayuela · Victoriano Mulero · Diana García-MorenoFrontiers in Cell and Developmental Biologydoi 10.3389/fcell.2026.1899363
Original ResearchPublished 24 September 2026Comparative effectiveness and safety of topiramate versus amitriptyline for the prophylactic management of chronic migraine: a prospective comparative studyMohammed Matoog Karami · Amber Hassan · Amal Alkhotani · Mazen Basheikh · Adnan Badahdah · Raed Gasemaltayeb · Ahmed Bamaga · Taghreed Alsinani · Rakan Bokhari · Abdulrahman Almazrooa · Siti Sarah Maidin · Humaira Waseem · Muhammad Anjum · Maher KurdiFrontiers in Pain Researchdoi 10.3389/fpain.2026.1923623
Systematic ReviewPublished 27 March 2026Risk of neurodevelopmental disorders after fetal topiramate exposure: a systematic reviewRenate Eikevåg Lundøy · Anniken Sigvathsen · Marte-Helene Bjørk · Nils Erik Gilhus · Jenny Linnea Victoria LindroosFrontiers in Drug Safety and Regulationdoi 10.3389/fdsfr.2026.1761506
